 Tissue dose estimates selective uptake thymidine precursors resistant tumours purposes evaluation therapeutic potential radiohalogenated thymidine analogue estimation radiation dose tumour cells normal tissues important dose tissue radionuclide simple major emissions short-range Auger electrons cytotoxicity dependent position decay relative DNA principal target cell sterilization Estimates cytotoxicity traditional MIRD formulation ICRU Report gross underestimates DNA thymidine precursor work tissue count autoradiography ARG data studies Bagshawe al tissue doses administration colorectal carcinoma choriocarcinoma tumour-bearing animals hydroxyurea block normal tissue turnover tumour cell toxicity ARG data degree incorporation cell Major drawbacks type therapy long half-life radiological waste disposal problems extreme short range radiotoxic effects Possible alternative radiohalogens place thymidine analog iododeoxyuridine Dose calculations cytotoxicities assumption biological retention characteristics